Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to (2022 - 2025)

Report Code: BT 3161 Mar, 2021, by marketsandmarkets.com

[316 Pages Report] The global dPCR and qPCR market is projected to reach USD 7.6 billion by 2025, at a CAGR of 9.0% between 2020 and 2025. Technological advancements in PCR technologies coupled with product developments by key players is driving the market growth. For instance, several market players have developed novel qPCR and dPCR products capable of detecting a large number of genetic mutations or identifying different pathogens. On the other hand, expensive instruments along with technical constraints of PCR are expected to hinder the market growth.

Digital PCR and Real-time PCR (qPCR) Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the dPCR and qPCR market

The COVID-19 pandemic severely affected the healthcare sector. The diagnostics industry was the most impacted and a surge in PCR market has been observed. Digital PCR and real-time PCR have witnessed significant demand as they are utilized for diagnostic and drug discovery. Growing focus of industry players tests to detect COVID-19 by developing droplet digital PCR kit is witnessed. There has been extensive support by regulatory authorities to approve these tests to curb the consequences of the COVID-19 pandemic.

Business models of several companies have been modified in order to sustain the pandemic situation and boost its revenue growth. Furthermore, some key players are focusing on developments to boost the PCR market. For instance, Thermo Fisher developed several PCR kits and assays for diagnostics and research applications to combat the COVID-19 outbreak,. The company received the US FDA emergency use authorization (EUA) for SARS‑CoV‑2 multiplex real-time PCR test and also launched AcroMetrix Coronavirus 2019 (COVID-19) RNA Control in 2020.

Some key developments in the PCR industry are mentioned below:

  • In 2020, Bio-Rad received FDA emergency use authorization for the Droplet Digital PCR SARS-CoV-2 Test Kit.
  • To combat the COVID-19 outbreak, Thermo Fisher developed several PCR kits and assays for diagnostics and research applications. The company received the US FDA emergency use authorization (EUA) for SARS‑CoV‑2 multiplex real-time PCR test and also launched AcroMetrix Coronavirus 2019 (COVID-19) RNA Control in 2020.
  • In 2020, bioMιrieux S.A. received the CE Mark approval for SARS-CoV-2 R-GENE tests to include saliva specimens. The company also received emergency use authorization for the BioFire COVID-19 test.
  • In 2020, Danaher Corporation received the US FDA Emergency Use Authorization (EUA) for the Xpert Xpress SARS-CoV-2 test.

Global dPCR and qPCR Market Dynamics

DRIVER: Rising investments, funds, and grants

The increasing consumer demand for early disease diagnosis and treatment has driven the pace of R&D into innovative genetic technologies and product development. This rise in R&D activity is supported by an increase in investments and the availability of funds and grants. In addition, government and federal agencies across the globe are increasingly recognizing the role played by qPCR and dPCR products in genomics-based research. During the past decade, the qPCR and dPCR market has witnessed several funding initiatives by government and private agencies to support genomic research.

RESTRAINT: Technical limitations of qPCR and dPCR techniques

A typical qPCR/dPCR method is associated with several technical limitations such as signal measurement during the exponential phase of the PCR reaction, the need for optimization and validation of assay procedures, hindrances in target detection due to the presence of reaction inhibitors, and the failure to detect target molecules due to the low quality of the nucleotide template. In addition, qPCR and dPCR reagents have several procedural limitations that directly affect their adoption in genomic research, such as chemical binding of the reagent to dsDNA (SYBR Green dye), inability to assess DNA quality (AluQuant), and the use of carcinogenic chemicals (Yield gel).

OPPORTUNITY: Shift from plant-derived to genome-based drug discovery

Plant-derived drug candidates used for disease management often belong to a chemically similar class of natural products that show almost identical biological activity and often result in a similar set of therapeutic limitations (side-effects, contraindications, dose limits, and site of action). In addition, these natural products may have an unknown site of biological action that leads to unpredictable biological activity and side effects. The therapeutic limitations of plant-derived drugs can be addressed with gene-based drug candidates that have known sites of action (specific genes or proteins).

CHALLENGES: Adoption and implementation of MIQE guidelines

The main challenge for universal adoption and acceptance of MIQE guidelines includes tedious preparation and considerations needed prior to performing the actual PCR procedure. These considerations pertain to sample storage conditions, reactant quality, and extraction method, among other factors. These factors have restrained the adoption of MIQE guidelines among researchers, which is evident from the fact that, in 2013, only 7% of the published qPCR-based research papers cited MIQE guidelines (Source: The International Journal of Life Science Methods). This underscores the huge trust deficit among researchers that currently exist globally for adopting qPCR and dPCR techniques in genomic analysis. This is a significant challenge to the growth of the qPCR and dPCR market.

The hospitals and diagnostic centers held the largest share of the dPCR market, by end user

The hospitals and diagnostic centers segment accounted for the largest share of the market. This can be attributed to the growing demand for early and efficient disease diagnosis and treatment, increasing number of dPCR product launches for diagnostic applications, benefits offered by dPCR in disease diagnosis (as compared to other PCR technologies), and the growing public awareness related to the benefits offered by dPCR in disease diagnosis.

The research application segment (of qPCR) comprised the second largest market share during the forecast period.

qPCR analysis is a widely used technique in research, especially in gene-based research to detect gene aberrations & mutations, identify specific genetic markers in oncology-based studies and genomic studies, and drug screening and lead identification in drug discovery. The evolving global regulatory scenario supports this market segment's growth for research data publication in qPCR-based research, increasing qPCR-based genomic studies, and the ongoing trend of laboratory automation and integration of robotics with qPCR workflows.

Digital PCR and Real-time PCR (qPCR) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Asia Pacific is anticipated to grow at a fastest growth rate during the forecast period.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period primarily due to the ongoing expansion and modernization of the healthcare infrastructure in emerging Asian countries, increasing number of research projects in China, India, and Japan in the field of genomics and oncology, rising trend of clinical research being outsourced to Asia-based CROs by leading drug manufacturing companies, and continuous government support for genomics-based research activities in emerging Asia Pacific countries.

Key Market Players

Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland) are the key players operating in this market. Other prominent players are Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Switzerland), Becton Dikinson and Company (US), bioMιrieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA  (Germany), QIAGEN N.V.  (Netherlands), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), and Quidel Corporation (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2016–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Billion)

Segments covered

Product and service , application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latina America, and Middle East and Africa

Companies covered

Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Switzerland), Becton Dikinson and Company (US), bioMιrieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA  (Germany), QIAGEN N.V.  (Netherlands), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), and Quidel Corporation (US).

This report categorizes the dPCR and qPCR market into the following segments and subsegments

dPCR and qPCR Market, By Product & Service

  • qPCR Products & Services
    • qPCR Reagents and Consumables
    • qPCR Instruments
    • qPCR Software and Services
  • dPCR Products & Services
    • dPCR Instruments
    • dPCR Reagents and Consumables
    • dPCR Software and Services

dPCR and qPCR Market, By Application

  • qPCR Applications
    • Clinical Applications
    • Research Applications
    • Forensic Applications
  • dPCR Applications
    • Clinical Applications
    • Research Applications
    • Forensic Applications

dPCR and qPCR Market, By End User

  • qPCR End User
    • Hospitals and Diagnostic Centers
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories
  • qPCR End User
    • Hospitals and Diagnostic Centers
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories

Recent Developments

  • In 2020, Thermo Fisher Scientific, Inc  received US FDA emergency use authorization (EUA) for SARS‑CoV‑2 multiplex real-time PCR test.
  • In 2020, Roche Diagnostics received US FDA 510k clearance for cobas BKV test.
  • In 2020, Abbott Laboratories received US FDA EUA ALINITY m SARS-CoV-2 ASSAY
  • In 2019, Bio-Rad Laboratories, Inc. Received the US FDA’s approval for its QXDx AutoDG ddPCR System and the QXDx BCR-ABL %IS Kit.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 35)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES
        FIGURE 1 THE MARKET FOR DPCR AND QPCR IS EXPECTED TO WITNESS ROBUST GROWTH DURING THE FORECAST PERIOD, COMPARED WITH THE PREVIOUS ESTIMATES OF THIS MARKET

2 RESEARCH METHODOLOGY (Page No. - 40)
    2.1 RESEARCH DATA
        FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primaries
    2.2 MARKET ESTIMATION METHODOLOGY
        FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
           2.2.2 USAGE-BASED MARKET ESTIMATION
                 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL DPCR AND QPCR MARKET
           2.2.3 GROWTH FORECAST
           2.2.4 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY)
           2.2.5 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
        FIGURE 5 DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 50)
  FIGURE 6 GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 7 GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 8 GLOBAL QPCR MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  FIGURE 9 GLOBAL DPCR MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  FIGURE 10 DPCR AND QPCR MARKET: GEOGRAPHIC SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 GLOBAL DPCR AND QPCR MARKET OVERVIEW
        FIGURE 11 RISING INCIDENCE OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICAN DPCR MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
        FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE DPCR MARKET DURING THE FORECAST PERIOD
    4.3 GEOGRAPHICAL SNAPSHOT OF THE DPCR AND QPCR MARKET
        FIGURE 13 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 60)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 KEY MARKET DRIVERS
                    5.2.1.1 Rising incidence of target infectious diseases and genetic disorders
                            FIGURE 15 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2019
                            FIGURE 16 GROWING GERIATRIC POPULATION ACROSS KEY REGIONS (2017 VS. 2030)
                    5.2.1.2 Technological advancements in PCR technologies
                            FIGURE 17 TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY
                    5.2.1.3 Increasing investments, funds, and grants
                    5.2.1.4 Increasing use of biomarker profiling for disease diagnostics
                    5.2.1.5 Successful completion of the Human Genome Project
           5.2.2 KEY MARKET RESTRAINTS
                    5.2.2.1 High device costs associated with dPCR
                    5.2.2.2 Technical limitations of qPCR and dPCR techniques
           5.2.3 KEY MARKET OPPORTUNITIES
                    5.2.3.1 Growing market penetration in emerging countries
                    5.2.3.2 Shift from plant-derived to genome-based drug discovery
           5.2.4 KEY MARKET CHALLENGES
                    5.2.4.1 Adoption and implementation of MIQE guidelines
           5.2.5 KEY MARKET TRENDS
                    5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices
                    5.2.5.2 Ongoing technological integration with the PCR process
    5.3 COVID-19 IMPACT ON THE DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET

6 DPCR AND QPCR MARKET, BY PRODUCT & SERVICE (Page No. - 69)
    6.1 INTRODUCTION
        TABLE 1 DPCR AND QPCR MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
        TABLE 2 DPCR AND QPCR MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
    6.2 QPCR PRODUCTS & SERVICES
        TABLE 3 QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)
        TABLE 4 QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2025 (USD MILLION)
        TABLE 5 QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
        TABLE 6 QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
           6.2.1 QPCR REAGENTS AND CONSUMABLES
                 TABLE 7 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 8 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
                    6.2.1.1 qPCR reagents and consumables market, by application
                            TABLE 9 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                            TABLE 10 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                    6.2.1.2 qPCR reagents and consumables market, by end user
                            TABLE 11 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2016–2019 (USD MILLION)
                            TABLE 12 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2020–2025 (USD MILLION)
           6.2.2 QPCR INSTRUMENTS
                 TABLE 13 QPCR INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 14 QPCR INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    6.2.2.1 qPCR instruments market, by application
                            TABLE 15 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                            TABLE 16 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                    6.2.2.2 qPCR instruments market, by end user
                            TABLE 17 QPCR INSTRUMENTS MARKET, BY END USER, 2016–2019 (USD MILLION)
                            TABLE 18 QPCR INSTRUMENTS MARKET, BY END USER, 2020–2025 (USD MILLION)
           6.2.3 QPCR SOFTWARE AND SERVICES
                 TABLE 19 QPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 20 QPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
                    6.2.3.1 qPCR software and services market, by application
                            TABLE 21 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                            TABLE 22 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                    6.2.3.2 qPCR software and services market, by end user
                            TABLE 23 QPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2016–2019 (USD MILLION)
                            TABLE 24 QPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
    6.3 DPCR PRODUCTS & SERVICES
        TABLE 25 DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)
        TABLE 26 DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2025 (USD MILLION)
        TABLE 27 DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
        TABLE 28 DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
           6.3.1 DPCR INSTRUMENTS
                 TABLE 29 DPCR INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 30 DPCR INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    6.3.1.1 dPCR instruments market, by application
                            TABLE 31 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                    6.3.1.2 dPCR instruments market, by application
                            TABLE 32 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                    6.3.1.3 dPCR instruments market, by end user
                            TABLE 33 DPCR INSTRUMENTS MARKET, BY END USER, 2016–2019 (USD MILLION)
                            TABLE 34 DPCR INSTRUMENTS MARKET, BY END USER, 2020–2025 (USD MILLION)
           6.3.2 DPCR REAGENTS AND CONSUMABLES
                 TABLE 35 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 36 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
                    6.3.2.1 dPCR reagents and consumables market, by application
                            TABLE 37 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                            TABLE 38 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                    6.3.2.2 dPCR reagents and consumables market, by end user
                            TABLE 39 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2016–2019 (USD MILLION)
                            TABLE 40 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2020–2025 (USD MILLION)
           6.3.3 DPCR SOFTWARE AND SERVICES
                 TABLE 41 DPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 42 DPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
                    6.3.3.1 dPCR software and services market, by application
                            TABLE 43 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                    6.3.3.2 dPCR software and services market, by application
                            TABLE 44 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                    6.3.3.3 dPCR software and services market, by end user
                            TABLE 45 DPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2016–2019 (USD MILLION)
                            TABLE 46 DPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2020–2025 (USD MILLION)

7 DPCR AND QPCR MARKET, BY APPLICATION (Page No. - 97)
    7.1 INTRODUCTION
    7.2 QPCR APPLICATIONS
        TABLE 47 GLOBAL QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 48 GLOBAL QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           7.2.1 CLINICAL APPLICATIONS
                 TABLE 49 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                 TABLE 50 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                 TABLE 51 QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 52 QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    7.2.1.1 Infectious disease testing
                               7.2.1.1.1 The wide availability of qPCR assays and kits for infectious disease testing is a key factor driving market growth
                                         TABLE 53 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 54 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020–2025 (USD MILLION)
                    7.2.1.2 Oncology testing
                               7.2.1.2.1 The advent of alternative diagnostic technologies for oncology testing is a key factor restraining market growth
                                         TABLE 55 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 56 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2020–2025 (USD MILLION)
                    7.2.1.3 Blood screening
                               7.2.1.3.1 The elimination of post-amplification processing and easy process automation to drive the demand for qPCR products
                                         TABLE 57 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 58 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2020–2025 (USD MILLION)
                    7.2.1.4 Transplant diagnostics
                               7.2.1.4.1 Increasing commercialization of qPCR products for transplant diagnostics to drive the market growth
                                         TABLE 59 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 60 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2020–2025 (USD MILLION)
                    7.2.1.5 Other clinical applications
                            TABLE 61 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
                            TABLE 62 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           7.2.2 RESEARCH APPLICATIONS
                    7.2.2.1 Increase in genome-based research activity boosts the market growth
                            TABLE 63 QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
                            TABLE 64 QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2020 –2025 (USD MILLION)
           7.2.3 FORENSIC APPLICATIONS
                    7.2.3.1 Limited adoption of qPCR in underdeveloped and developing countries is expected to restrict the market growth
                            TABLE 65 QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
                            TABLE 66 QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
    7.3 DPCR APPLICATIONS
        TABLE 67 GLOBAL DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 68 GLOBAL DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           7.3.1 CLINICAL APPLICATIONS
                 TABLE 69 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                 TABLE 70 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                 TABLE 71 DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 72 DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    7.3.1.1 Infectious disease testing
                               7.3.1.1.1 Accuracy and precision of dPCR have made it a prominent tool in infectious disease testing
                                         TABLE 73 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 74 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020–2025 (USD MILLION)
                    7.3.1.2 Oncology testing
                               7.3.1.2.1 dPCR plays a vital role in oncology testing and clinical studies
                                         TABLE 75 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 76 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2020–2025 (USD MILLION)
                    7.3.1.3 Blood screening
                               7.3.1.3.1 dPCR offers multiple advantages over traditional techniques for blood screening
                                         TABLE 77 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 78 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2020–2025 (USD MILLION)
                    7.3.1.4 Transplant diagnostics
                               7.3.1.4.1 Low market availability of dPCR products for transplant diagnostics to reflect in the small share of this segment
                                         TABLE 79 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2016–2019 (USD MILLION)
                                         TABLE 80 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2020–2025 (USD MILLION)
                    7.3.1.5 Other clinical applications
                            TABLE 81 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
                            TABLE 82 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           7.3.2 RESEARCH APPLICATIONS
                    7.3.2.1 Wide usage of dPCR in genetic research is the primary driver for market growth
                            TABLE 83 DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
                            TABLE 84 DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.3 FORENSIC APPLICATIONS
                    7.3.3.1 The need to reduce the time & cost of forensic processes is a key factor driving market growth
                            TABLE 85 DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
                            TABLE 86 DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)

8 DPCR AND QPCR MARKET, BY END USER (Page No. - 125)
    8.1 INTRODUCTION
    8.2 QPCR END USERS
        TABLE 87 QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 88 QPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
           8.2.1 HOSPITALS AND DIAGNOSTIC CENTERS
                 TABLE 89 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 90 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2025 (USD MILLION)
           8.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
                 TABLE 91 QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 92 QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2020–2025 (USD MILLION)
           8.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
                 TABLE 93 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 94 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2025 (USD MILLION)
           8.2.4 CLINICAL RESEARCH ORGANIZATIONS
                 TABLE 95 QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 96 QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.2.5 FORENSIC LABORATORIES
                 TABLE 97 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 98 I QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2020–2025 (USD MILLION)
    8.3 DPCR END USERS
        TABLE 99 DPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 100 DPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
           8.3.1 HOSPITALS AND DIAGNOSTIC CENTERS
                 TABLE 101 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 102 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2025 (USD MILLION)
           8.3.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
                 TABLE 103 DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 104 DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2020–2025 (USD MILLION)
           8.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
                 TABLE 105 DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 106 DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2025 (USD MILLION)
           8.3.4 CLINICAL RESEARCH ORGANIZATIONS
                 TABLE 107 DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 108 DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.3.5 FORENSIC LABORATORIES
                 TABLE 109 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2016–2019 (USD MILLION)
                 TABLE 110 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2020–2025 (USD MILLION)

9 DPCR AND QPCR MARKET, BY REGION (Page No. - 144)
    9.1 INTRODUCTION
        TABLE 111 DPCR AND QPCR MARKET, BY REGION, 2016–2019 (USD MILLION)
        TABLE 112 DPCR AND QPCR MARKET, BY REGION, 2020–2025 (USD MILLION)
    9.2 NORTH AMERICA
        FIGURE 18 NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT
        TABLE 113 NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 114 NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 115 NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 116 NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 117 NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 118 NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 119 NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 120 NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 121 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 122 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 123 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 124 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 125 NORTH AMERICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 126 NORTH AMERICA: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
        TABLE 127 NORTH AMERICA: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 128 NORTH AMERICA: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 The US dominated the North American dPCR and qPCR market in 2019
                            TABLE 129 US: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 130 US: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 131 US: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 132 US: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada
                            TABLE 133 CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 134 CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 135 CANADA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 136 CANADA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
    9.3 EUROPE
        TABLE 137 EUROPE: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 138 EUROPE: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 139 EUROPE: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 140 EUROPE: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 141 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 142 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 143 EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 144 EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 145 EUROPE: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 146 EUROPE: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 147 EUROPE: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 148 EUROPE: DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 149 EUROPE: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 150 EUROPE: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
        TABLE 151 EUROPE: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 152 EUROPE: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany dominates the European dPCR and qPCR market
                            TABLE 153 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 154 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 155 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 156 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Growing focus on genomics research to support market growth in the UK
                            TABLE 157 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 158 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 159 UK: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 160 UK: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Initiatives for developing genomic medicine to support market growth in France
                            TABLE 161 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 162 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 163 FRANCE: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 164 FRANCE: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.3.4 REST OF EUROPE
                 TABLE 165 ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                 TABLE 166 ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                 TABLE 167 ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                 TABLE 168 ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
    9.4 ASIA PACIFIC
        FIGURE 19 ASIA PACIFIC: DPCR AND QPCR MARKET SNAPSHOT
        TABLE 169 APAC: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 170 APAC: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 171 APAC: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 172 APAC: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 173 ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 174 ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 175 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 176 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 177 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 178 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 179 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 180 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 181 ASIA PACIFIC: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 182 ASIA PACIFIC: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
        TABLE 183 ASIA PACIFIC: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 184 ASIA PACIFIC: DPCR MARKET, BY END USER, 2020–2025(USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan
                            TABLE 185 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 186 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 187 JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 188 JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Healthcare infrastructure modernization to support market growth in China
                            TABLE 189 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 190 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 191 CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 192 CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Presence of a large target patient population to support market growth in India
                            TABLE 193 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 194 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 195 INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 196 INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.4.4 REST OF APAC
                            TABLE 197 ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 198 ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 199 ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 200 ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
    9.5 LATIN AMERICA
        TABLE 201 LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 202 LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 203 LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
        TABLE 204 LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
        TABLE 205 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 206 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 207 LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
        TABLE 208 LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
        TABLE 209 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
        TABLE 210 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
        TABLE 211 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2016 -2019 (USD MILLION)
        TABLE 212 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2020 -2025 (USD MILLION)
        TABLE 213 LATIN AMERICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 214 LATIN AMERICA: QPCR MARKET, BY END USER, 2020–2025(USD MILLION)
        TABLE 215 LATIN AMERICA: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
        TABLE 216 LATIN AMERICA: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Brazil dominates the LATAM market
                            TABLE 217 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 218 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2020--2025 (USD MILLION)
                            TABLE 219 BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 220 BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Favorable trade agreements will support imports and improve access to dPCR and qPCR instruments in Mexico
                            TABLE 221 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 222 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 223 MEXICO: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 224 MEXICO: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                            TABLE 225 ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 226 ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                            TABLE 227 ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                            TABLE 228 ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           9.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA
                 TABLE 229 MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                 TABLE 230 MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                 TABLE 231 MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
                 TABLE 232 MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
                 TABLE 233 MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                 TABLE 234 MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                 TABLE 235 MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                 TABLE 236 MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
                 TABLE 237 MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
                 TABLE 238 MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
                 TABLE 239 MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER, 2016–2020 (USD MILLION)
                 TABLE 240 MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 209)
     10.1 OVERVIEW
          FIGURE 20 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DPCR AND QPCR MARKET, 2016–2020
     10.2 MARKET SHARE ANALYSIS
             10.2.1 QPCR MARKET SHARE ANALYSIS (2019)
                    FIGURE 21 QPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
             10.2.2 DPCR MARKET SHARE ANALYSIS (2019)
                    FIGURE 22 DPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
     10.3 COMPETITIVE SCENARIO
             10.3.1 KEY PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (2016–2020)
             10.3.2 KEY PARTNERSHIPS AND COLLABORATIONS (2016–2020)
             10.3.3 KEY ACQUISITIONS (2016–2020)
             10.3.4 KEY EXPANSIONS (2016–2020)
     10.4 DIGITAL PCR AND REAL-TIME (QPCR) MARKET: COMPANY EVALUATION QUADRANT, 2019
             10.4.1 COMPANY EVALUATION QUADRANT: MAJOR MARKET PLAYERS (2018)
                        10.4.1.1 Stars
                        10.4.1.2 Emerging Leaders
                        10.4.1.3 Pervasive
                        10.4.1.4 Emerging Companies
                                 FIGURE 23 GLOBAL COMPANY EVALUATION QUADRANT (OVERALL MARKET)
             10.4.2 OMPANY EVALUATION QUADRANT: EMERGING COMPANIES/SMES/START-UPS (2018)
                        10.4.2.1 Progressive Companies
                        10.4.2.2 Starting Blocks
                        10.4.2.3 Responsive Companies
                        10.4.2.4 Dynamic Companies
                                 FIGURE 24 COMPANY EVALUATION QUADRANT (SMES/START-UPS)

11 COMPANY PROFILES (Page No. - 219)
(Business overview, Products and Services offered, Recent developments & MnM View)*
     11.1 THERMO FISHER SCIENTIFIC
          FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
     11.2 BIO-RAD LABORATORIES
          FIGURE 26 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
     11.3 ROCHE DIAGNOSTICS
          FIGURE 27 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
     11.4 ABBOTT LABORATORIES
          FIGURE 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
     11.5 AGILENT TECHNOLOGIES
          FIGURE 29 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
     11.6 ANALYTIK JENA AG
          FIGURE 30 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2019)
     11.7 BECTON DICKINSON AND COMPANY
          FIGURE 31 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
     11.8 BIOMΙRIEUX S.A.
          FIGURE 32 BIOMΙRIEUX S.A.: COMPANY SNAPSHOT (2019)
     11.9 DANAHER CORPORATION
          FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
     11.10 EPPENDORF AG
           FIGURE 34 EPPENDORF AG: COMPANY SNAPSHOT (2019)
     11.11 FLUIDIGM CORPORATION
           FIGURE 35 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019)
     11.12 MERCK KGAA
           FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019)
     11.13 QIAGEN N.V.
           FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
     11.14 TAKARA BIO
           FIGURE 38 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019)
     11.15 MERIDIAN BIOSCIENCE
           FIGURE 39 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2019)
     11.16 QUIDEL CORPORATION
           FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2019)
     11.17 PROMEGA CORPORATION
     11.18 ENZO LIFE SCIENCES
     11.19 BIONEER CORPORATION
     11.20 ELITECH GROUP
     11.21 QUANTA BIOSCIENCES
     11.22 SACACE BIOTECHNOLOGIES S.R.L.
     11.23 BIO MOLECULAR SYSTEMS
     11.24 BIOMEME
     11.25 JN MEDSYS PTE. LTD.
     11.26 STILLA TECHNOLOGIES
     11.27 KYRATEC
     11.28 LGC BIOSEARCH TECHNOLOGIES
           FIGURE 41 LGC SCIENCE GROUP HOLDINGS LIMITED: COMPANY SNAPSHOT (2019)
     11.29 COLE-PARMER INSTRUMENT COMPANY
     11.30 GENOME DIAGNOSTICS PVT. LTD.

*Details on Business overview, Products and Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.

12 ADJACENT RELATED MARKET (Page No. - 300)
     12.1 INTRODUCTION
     12.2 LIMITATIONS
     12.3 MOLECULAR DIAGNOSTIC MARKET
             12.3.1 MARKET DEFINATION
             12.3.2 MARKET OVERVIEW
             12.3.3 MOLECULAR DIAGNOSTICS MARKET, BY REGION
                    TABLE 241 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
                        12.3.3.1 North America
                                 TABLE 242 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
                        12.3.3.2 Europe
                                 TABLE 243 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
                        12.3.3.3 Asia pacific
                                 TABLE 244 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
                        12.3.3.4 Rest of the World
                                 TABLE 245 ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
     12.4 IN VITRO DIAGNOSTIC (IVD) MARKET
             12.4.1 MARKET DEFINATION
             12.4.2 MARKET OVERVIEW
             12.4.3 IN VITRO DIAGNOSTIC MARKET, BY REGION
                    TABLE 246 IVD MARKET, BY REGION, 2018–2025 (USD MILLION)
                        12.4.3.1 North America
                                 TABLE 247 NORTH AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                        12.4.3.2 Europe
                                 TABLE 248 EUROPE: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                        12.4.3.3 Asia Pacific
                                 TABLE 249 ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
     12.5 LIFE SCIENCE INSTRUMENTATION MARKET
             12.5.1 MARKET DEFINITION
             12.5.2 MARKET OVERVIEW
             12.5.3 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION
                    TABLE 250 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION, 2017–2025 (USD MILLION)
                        12.5.3.1 North America
                                 TABLE 251 NORTH AMERICA LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
                        12.5.3.2 Europe
                                 TABLE 252 EUROPE LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
                        12.5.3.3 Asia Pacific
                                 TABLE 253 ASIA PACIFIC LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION)

13 APPENDIX (Page No. - 309)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global dPCR and qPCR market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the dPCR and qPCR market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Data

This research study involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies’ house documents, investor presentations, and SEC filings of companies. The secondary sources referred to for (this research study include publications from government sources, such as World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), Global Cancer Observatory (GLOBOCAN), World Bank, Joint United Nations Programme on HIV and AIDS (UNAIDS), International Trade Administration, National Human Genome Research Institute (NHGRI),, Institute for Health Metrics and Evaluation (US), US FDA, Health Canada, European Medicines Agency (UK), German Cancer Research Center, NHS (UK), Medicines and Healthcare Products Regulatory Agency (UK), UK Biobank, French National Research Agency (France), Italian National Institute of Health, Pharmaceuticals and Medical Devices Agency (Japan), National Cancer Center (Japan), Beijing Institute of Genomics (China), Chinese Academy of Sciences, Ministry of Science & Technology (India), Ministry of Health and Family Welfare (India), Brazilian Health Regulatory Agency (Brazil), African Cancer Registry Network (UK) among others.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the dPCR and qPCR market. It was also used to obtain important information about the key players and market classification, segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Data

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

Primary sources from demand side includes personnel from pharmaceutical and biotechnology companies and academic and research institutes, and purchase managers in healthcare provider organizations and supply-side includes C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others.

Primary research was used in this report to:

  • Validate the market segmentation defined through product portfolio assessment of leading players in the dPCR and qPCR market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of key factors affecting the market growth (such as market drivers, challenges, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the dPCR and qPCR market and their market share/ranking

Digital PCR and Real-time PCR (qPCR) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the dPCR and qPCR market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the  dPCR and qPCR market

Report Objectives

  • To define, describe, segment, and forecast the dPCR and qPCR market on the basis of product & services,  application, end user, and region
  • To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall dPCR and qPCR market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
  • To strategically profile the key players in the global dPCR and qPCR market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments, such as product launches & approvals, acquisitions, collaborations, agreements, expansions, and partnerships in the dPCR and qPCR market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the European dPCR and qPCR market into countries from the Rest of Europe segment.
  • Further breakdown of the Asia Pacific dPCR and qPCR market into countries from the Rest of the APAC segment.
  • Further breakdown of Rest of Latin America and the Middle East & Africa dPCR and qPCR market into countries.

Company Information

Detailed analysis and profiling of additional market players (up to 5) inclusive of:

  • Business Overview
  • Financial Information
  • Product Offered
  • Developments (Last three years)
Report Code
BT 3161
Published ON
Mar, 2021
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved